10 Quick Tips About ADHD Medication Pregnancy > 자유게시판

• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The choice of whether to stop or continue ADHD medication during pregnancy and breastfeeding is challenging for women with the condition. Little data exists about how long-term exposure to these drugs can affect the foetus.

A study recently published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological problems like hearing loss or vision, febrile seizures or IQ impairment. The authors acknowledge that more high quality research is needed.

Risk/Benefit Analysis

Women who are expecting and taking ADHD medication must weigh the benefits of taking it against the possible risks for the baby. Physicians don't have the data to give clear advice but they can provide information on the risks and benefits to assist pregnant women to make an informed decision.

A study published in Molecular Psychiatry concluded that women who took ADHD medication during early pregnancy did not have a higher risk of fetal malformations, or structural birth defects. Researchers used a vast population-based study of case-control to evaluate the incidence of major structural birth defects in babies born to mothers who had taken stimulants during the early stages of pregnancy and those who had not. Pediatric cardiologists, clinical geneticists and other experts looked over the cases to ensure that the classification was correct and to minimize any bias.

The study of the researchers was not without its limitations. The researchers were not able to, in the first place to distinguish the effects triggered by the medication from the disorder. That limitation makes it difficult to determine whether the limited associations observed in the groups that were exposed are due to medication use or the confounding effect of comorbidities. Researchers also did not look at long-term outcomes for offspring.

The study did reveal that infants whose mothers took ADHD medication during pregnancy were at slightly higher risk of being admitted to the neonatal intensive care unit (NICU) than those who were born without any medication or taken off their medication prior to or during pregnancy. The reason for this was central nervous system disorders. The increased risk of admission was not influenced by the stimulant medication used during pregnancy.

Women who were taking stimulant adhd medication for women - published on Google - medication during pregnancy were also at an elevated chance of having a caesarean delivery or having a baby born with an low Apgar score (less than 7). These increases didn't appear to be affected by the type of medication that was used during pregnancy.

Researchers suggest that the small risks posed by the use of ADHD medication during pregnancies in the early stages may be offset by the greater benefits to both baby and mother of continued treatment for the woman’s disorder. Physicians should talk to their patients about this and as much as possible, assist them improve coping skills which may reduce the impact of her disorder in her daily functioning and her relationships.

Interactions with Medication

Doctors are increasingly confronted with the dilemma of whether to continue treatment or stop during pregnancy as more women are diagnosed with adhd medications for adults. The majority of these decisions are made without solid and reliable evidence in either case, which means that doctors have to weigh their experience about their experiences, the experiences of other doctors, and what research says on the topic and their best judgment for each individual patient.

Particularly, the issue of potential risks for the baby can be a challenge. Many of the studies on this issue are based on observational evidence rather than controlled research, and their findings are often contradictory. The majority of studies restrict their analysis to live births, which can underestimate the teratogenic impact that can lead to abortions or terminations of pregnancy. The study that is discussed in the journal club addresses these issues, by examining both data on live and deceased births.

Conclusion Some studies have revealed an association between ADHD medications and certain birth defects, other studies have not shown such a relationship. The majority of studies show an unintended, or slight negative impact. Therefore, a careful risk/benefit assessment must be done in each case.

It can be difficult, if not impossible for women suffering from private adhd assessment medway to stop taking their medication. In a recent piece published in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can cause depression and feelings of isolation. A decrease in medication could also affect the ability to safely drive and complete work-related tasks, which are vital aspects of everyday life for people with ADHD.

She suggests that women who are unsure about whether or not to stop taking medication because of their pregnancy consider the possibility of educating friends, family members, and coworkers on the condition, its effects on daily functioning, and the advantages of continuing the current treatment plan. It can also aid in ensuring that the woman feels supported in her struggle with her decision. It is important to note that some drugs can pass through the placenta, therefore, if a patient decides to discontinue her ADHD medication during pregnancy and breastfeeding, she must be aware of the possibility that traces of the drug can be passed on to the baby.

Birth Defects Risk

As the use of ADHD medication to treat the symptoms of attention deficit hyperactivity disorder (ADHD) increases, so do concerns about the effects that the drugs might have on fetuses. Recent research published in the journal Molecular Psychiatry has added to the body knowledge on this issue. Researchers used two huge datasets to analyze more than 4.3 million pregnancy and determine if the use of stimulant medications increased birth defects. While the overall risk is low, the researchers did find that first-trimester exposure to ADHD medications was associated with a slightly higher rate of certain heart defects, such as ventriculoseptal defect (VSD).

The researchers of the study didn't find any association between early medication usage and congenital anomalies like facial deformities, or club feet. The results are in line with previous studies which showed a small, but significant increase in cardiac malformations for women who started taking ADHD medication prior to the time of pregnancy. The risk grew in the latter half of pregnancy, when many women decide to stop taking their strattera adhd medication medications.

Women who used ADHD medications in the first trimester of their pregnancy were also more likely to have caesarean section, low Apgar score following delivery, and a baby who required help breathing at birth. However the researchers of the study were not able to eliminate bias due to selection by restricting the study to women who did not have other medical issues that could have contributed to these findings.

Researchers hope that their research will help doctors when they see pregnant women. The researchers suggest that while discussing risks and benefits are important, the choice regarding whether or not to stop medication should be made in light of the severity of each woman's ADHD symptoms and her requirements.

The authors also warn that even though stopping the medication is an alternative, it is not an option to consider due to the high rate of depression and other mental health problems in women who are pregnant or postpartum. Furthermore, research suggests that women who choose to stop taking their medications are more likely to experience a difficult time adjusting to life without them after the baby's arrival.

Nursing

It can be a challenge to become a mom. Women who suffer from ADHD may face a lot of challenges when they must deal with their symptoms, attend doctor appointments, prepare for the birth of a child and adjust to new routines. Many women opt to continue taking their most effective adhd medication for adults medication during pregnancy.

The majority of stimulant medications pass through breast milk in very small amounts, so the risk for infant who is breastfeeding is low. The rate of medication exposure will differ based on dosage and frequency of administration as well as time of day. In addition, individual medications enter the body of the baby differently through the gastrointestinal tract and breast milk and the impact of this on a newborn infant is not fully known.

Some physicians may discontinue stimulant medication during a woman’s pregnancy due to the lack of research. This is a difficult decision for the mother, who must weigh the advantages of continuing her medication against the risk to the foetus. In the meantime, until more information is available, GPs should ask all pregnant patients about their experience with adhd stimulant medication and whether they plan or are taking to take medication during the perinatal period.

Many studies have shown that women can continue taking their ADHD medication without risk during pregnancy and while breast-feeding. In response, a rising number of patients are opting to do so. They have found, in consultation with their doctors, that the benefits of retaining their current medication outweigh potential risks.

It's important for women with ADHD who are thinking of breastfeeding to seek out a specialist psychiatrist's guidance prior to becoming pregnant. They should discuss the medication they are taking with their physician, and the pros and cons for continuing treatment. This includes non-pharmacological strategies. Psychoeducation should also be offered to help women with ADHD understand their symptoms and the root cause Learn about the available treatment options and reinforce existing strategies for coping. This should include an approach that is multidisciplinary, including the GP as well as obstetricians, psychiatry and obstetricians. Counselling for pregnancy should include the discussion of a plan for management for both mother and child, monitoring for signs of deterioration and the need for adjustments to the medication regimen.